Before signing patent reform legislation on Friday, September 16, 2011, President Obama spoke briefly of new federal innovation initiatives which include nanotech and cleantech.  More detailed information has been provided.

Nanowerk reports some of the developments:  "The National Institutes of Health will collaborate with the Defense Advanced Research Projects Agency (DARPA), and the U.S. Food and Drug Administration to develop a chip to screen for safe and effective drugs far more swiftly and efficiently than current methods, and before they are tested in humans. The chip will be loaded with specific cell types that reflect human biology. It will be designed to allow multiple different readouts that can indicate whether a particular compound is likely to be safe or toxic for humans."

DARPA's press release, with an emphasis on vaccines, also was provided.  The NIH also had a press release.

Some of the political framework, if not controversy, has been noted in the press.

In addition, an additional NIH press release focused on more efficient exclusive license options for start-up companies as part of the administration's Startup America initiative.